Holdings, (OTCQB: CLSH) Record January
of $1.48 Million Beating Target
Miami, FL --
(February 9, 2021) – EmergingGrowth.com, a
leading independent small cap media portal with an extensive
history of providing unparalleled content for the Emerging Growth
markets and companies, reports on CLS Holdings, Inc. (OTCQB:
CLS Holdings, Inc. (OTCQB:
CLSH) just announced that the results for its
Nevada wholly owned subsidiaries for the month of January 2021 came
in with net revenues of $1.48 Million and Gross Margin of 50.4%.
The Company was targeting 50% gross margin.
CLS Holdings, Inc. (OTCQB: CLSH) by the numbers:
NET revenue for
January 2021 was $1.48 million beating January 2020 by 28.5% and
January 2019 by 100.4%
processed an average of over 700 transactions per day.
Revenue for the
six months ending November 30, 2020 came in at
Revenue for the
quarter ending November 30, 2020 of $4,907,889 represented a 61%
increase over the same quarter in 2019, and a 29.8% increase over
the first fiscal Q in 2021.
on its most recent quarter came in at $14,399,741.
may not be at these levels much longer.
CLS Holdings, Inc. (OTCQB: CLSH)
anticipates a continued rise in market penetration and growth
throughout the rest of 2021, and with an array of new products
launching in February and growth of the brand's new toll processing
division, Trichome Harvest Company, CLS Holdings expects to see
continued advancements in the coming months.
With many new operational
developments at City Trees, including the development of a new
division and rollout of new products, and increased sales at Oasis
Cannabis, the Company continued to make strides in expanding its
offerings and achieved its highest January revenue to
President and COO Andrew Glashow
stated "We started turning a corner as a community in the New
Year. We focused on providing accessible pricing and an
increasingly diverse menu of products at both City Trees and Oasis,
and people continued to respond. We leaned into what we're good at
- catering to locals, providing the best service, and providing
some of the best extraction products on the market through our
The company also
Trees, the Company's manufacturing subsidiary is now offering 5 new
distillate blends that are available in disposable vape pens,
cartridges, and refill oil applicators.
City Trees currently has over
70% market penetration and the brand is poised to continue growing
market share and strengthen its position as Nevada's premier
extract producer with the release of these new products.
This could be the biggest play we see in the cannabis space this
Companies in the news and featured on
Shares of stop sign company
Technologies, Inc. (OTC: INND), with no news or updates for at
least six months on OTCMarket.com awoke from an all but dead sleep
about one month ago to the day, trading at .0002 per share.
Over the past 30 days, the stock shot up almost 30,000% to .07 per
share. With no new information entering the market, that
topping tail from yesterday could be a sign of things to
Have a look
Holdings, Inc. (OTCQB: CLSH). They just came out
with record numbers and could be well in its way
When we first
we watched Innovation Pharmaceuticals, Inc. (OTCQB: IPIX) run 50%
and engulf its previous resistance of .299.
Since, it has
nearly doubled its valuation with what seems
record dollar volume. The big read bar from yesterday seems like
the run could be over, at least until more information comes to
light on OTCMarkets.com.
Check out CLS Holdings, Inc.
(OTCQB: CLSH) With 5 new products just
released, this could be the catalyst that brings the stock to trade
among the majors in the space.
Sunshine Biopharma, Inc. (OTC
Pink: SBFM) just engulfed its
entire charg going back to May of 2019
with yesterday's big green bar. News from February
is new to the
market since our last report. It would be perfectly healthy
at these levels for the stock to see a 50% retracement prior to its
Watch CLS Holdings, Inc. (OTCQB:
CLSH). The company anticipates a
continued rise in market penetration and growth throughout the rest
Shares of Enzolytics, Inc. (OTC Pink: ENZC) showed some promise last week after the announcement of the
discovery of seven newly identified conserved target sites on the
HIV virus. A SeekingAlpha.com article on January
seemed to be responsible for its 100% rise and subsequent 50%
fall. Since then the stock has rebounded and
like sunshine, a 50% retracement could be considered healthy before
its next run pending new information into the market.
In the meantime, Check out
CLS Holdings, Inc. (OTCQB: CLSH). This could be the biggest play in
the cannabis space this year.
About CLS Holdings USA,
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that
acts as an integrated cannabis producer and retailer through its
Oasis Cannabis subsidiaries in Nevada and plans to expand to other
states. CLS stands for "Cannabis Life Sciences," in recognition of
the Company's patented proprietary method of extracting various
cannabinoids from the marijuana plant and converting them into
products with a higher level of quality and consistency. The
Company's business model includes licensing operations, processing
operations, processing facilities, sale of products, brand creation
and consulting services.
Oasis Cannabis has operated a
cannabis dispensary in the Las Vegas market since dispensaries
first opened in Nevada in 2015 and has been recognized as one of
the top marijuana retailers in the state. Its location within
walking distance to the Las Vegas Strip and Downtown Las Vegas in
combination with its delivery service to residents allows it to
efficiently serve both locals and tourists in the Las Vegas area.
In February 2019, it was named "Best Dispensary for Pot Pros" by
Desert Companion Magazine. In August 2017, the company commenced
wholesale offerings of cannabis in Nevada with the launch of its
City Trees brand of cannabis concentrates and cannabis-infused
Founded in 2017, City Trees is a
Nevada-based cannabis cultivation, production and distribution
company. Offering a wide variety of products with consistent
results, City Trees products are available in numerous dispensaries
throughout the state of Nevada.
Market, or TAM, estimate is based on Nevada estimated sales data
provided by BDS Analytics for December 2020. This estimate is based
upon predicted results, is uncertain and involves known and unknown
uncertainties and other factors that may cause actual results to be
materially different from this estimate.
Figure reported as of
January 28, 2021. Additional sales may increase this total for the
remainder of January 2021.
This press release contains
certain ''forward-looking information'' within the meaning of
applicable Canadian securities legislation and ''forward-looking
statements'' as that term is defined in the Private Securities
Litigation Reform Act of 1995 (collectively, the ''forward-looking
statements''). These statements relate to, among other things, the
impact of the COVID-19 virus on our business, the results of our
initiatives to retain our employees and strengthen our
relationships with our customers and community during the pandemic,
the effect of our initiatives to expand market share and achieve
growth during and following the pandemic, results of operations and
financial performance, anticipated future events, and the
effectiveness of our business practices during the pandemic. The
continued spread of COVID-19 could have, and in some cases already
has had, an adverse impact on our business, operations and
financial results, including through disruptions in our cultivation
and processing activities, supply chains and sales channels, and
retail dispensary operations as well as a deterioration of general
economic conditions including a possible national or global
recession. Due to the speed with which the COVID-19 situation is
developing and the uncertainty of its magnitude, outcome and
duration, it is not possible to estimate its impact on our
business, operations or financial results; however, the impact
could be material. In some cases, you can identify forward
looking statements by terminology such as ''may,'' ''might,''
''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,''
''goals,'' ''projects,'' ''anticipates,'' ''believes,''
''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the
negative of these terms or other comparable terminology. These
forward-looking statements are only predictions, are uncertain and
involve substantial known and unknown risks, uncertainties and
other factors which may cause our actual results, levels of
activity or performance to be materially different from any future
results, levels of activity or performance expressed or implied by
these forward-looking statements. We cannot guarantee future
results, levels of activity or performance. You should not place
undue reliance on these forward-looking statements, which speak
only as of the date that they were made. These cautionary
statements should be considered together with any written or oral
forward-looking statements that we may issue in the future. Except
as required by applicable law, we do not intend to update any of
the forward-looking statements to conform these statements to
reflect actual results, later events or circumstances or to reflect
the occurrence of unanticipated events. See CLS Holdings USA
filings with the SEC and on its SEDAR profile at www.sedar.com for
Chairman and CEO
President and COO
Source: CLS Holdings USA,
Through its evolution, EmergingGrowth.com found
a niche in identifying companies that can be overlooked by the
markets. We look for strong management, innovation, strategy,
execution, and the overall potential for long- term growth. Aside
from being a trusted resource for the Emerging Growth info-seekers,
we are well known for discovering undervalued companies and
bringing them to the attention of the investment community. Through
our parent Company, we also have the ability to facilitate road
shows to present your products and services to the most influential
investment banks in the space.
contained herein as well as on the EmergingGrowth.com website
is obtained from sources believed to be reliable
and / or provided to EmergingGrowth.com by a third party,
but not guaranteed to be accurate or all-inclusive. All material
contained within this article, is
for informational purposes only, and
should not be construed as an offer or solicitation to buy or sell
information includes certain forward-looking statements, which may
be affected by unforeseen circumstances and / or certain
report is not without bias. EmergingGrowth.com has
motivation by means of either self-marketing or EmergingGrowth.com has
been compensated by or for a company or companies discussed in this
article. EmergingGrowth.com has
thousand five hundred dollars in consideration for its work with
CLS Holdings USA, Inc. EmergingGrowth.com can
receive future compensation and
has received additional past compensation, details about which can
be found in our full disclosure, which can be found
can easily lose money investing in highly speculative small cap
stocks like the ones mentioned within. Please consult an investment
professional before investing in anything viewed within.
When EmergingGrowth.com is
long shares it will sell those shares. In addition, please make
the Disclosure posted on the EmergingGrowth.com website.
Innovation Pharmaceuticals (QB) (USOTC:IPIX)
Historical Stock Chart
From Dec 2021 to Jan 2022
Innovation Pharmaceuticals (QB) (USOTC:IPIX)
Historical Stock Chart
From Jan 2021 to Jan 2022